|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de
Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, et al:
Therapeutic antibody targeting of individual Notch receptors.
Nature. 464:1052–1057. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang X, Qin J and Lu S: Up-regulation of
miR-877 induced by paclitaxel inhibits hepatocellular carcinoma
cell proliferation though targeting FOXM1. Int J Clin Exp Pathol.
8:1515–1524. 2015.PubMed/NCBI
|
|
7
|
Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ and
Wu F: Solitary large hepatocellular carcinoma: A specific subtype
of hepatocellular carcinoma with good outcome after hepatic
resection. Ann Surg. 249:118–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou YM, Zhang XF, Yu F, Liu XB, Wu LP, Li
B and Yang JM: Efficacy of surgical resection for pulmonary
metastases from hepatocellular carcinoma. Med Sci Monit.
20:1544–1549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen X, Bo L, Zhao X and Chen Q:
MicroRNA-133a inhibits cell proliferation, colony formation
ability, migration and invasion by targeting matrix
metallopeptidase 9 in hepatocellular carcinoma. Mol Med Rep.
11:3900–3907. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang ZQ, Meng H, Wang N, Liang LN, Liu
LN, Lu SM and Luan Y: Serum microRNA 143 and microRNA 215 as
potential biomarkers for the diagnosis of chronic hepatitis and
hepatocellular carcinoma. Diagn Pathol. 9:1352014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J: Control of protein synthesis and
mRNA degradation by microRNAs. Curr Opin Cell Biol. 20:214–221.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
15
|
Li B, Liu L, Li X and Wu L: miR-503
suppresses metastasis of hepatocellular carcinoma cell by targeting
PRMT1. Biochem Biophys Res Commun. 464:982–987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Fang L, Yu W and Wang Y:
MicroRNA-125b suppresses the migration and invasion of
hepatocellular carcinoma cells by targeting transcriptional
coactivator with PDZ-binding motif. Oncol Lett. 9:1971–1975. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng C, Li J, Wang Q, Liu W, Zhou J, Liu
R, Zeng Q, Peng X, Huang C, Cao P and Cao K: MicroRNA-195 functions
as a tumor suppressor by inhibiting CBX4 in hepatocellular
carcinoma. Oncol Rep. 33:1115–1122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong G and Xiong X: miR-205 promotes
proliferation and invasion of laryngeal squamous cell carcinoma by
suppressing CDK2AP1 expression. Biol Res. 48:602015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karaayvaz M, Zhang C, Liang S, Shroyer KR
and Ju J: Prognostic significance of miR-205 in endometrial cancer.
PLoS One. 7:e351582012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niu K, Shen W, Zhang Y, Zhao Y and Lu Y:
MiR-205 promotes motility of ovarian cancer cells via targeting
ZEB1. Gene. 574:330–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin C and Liang R: miR-205 promotes
epithelial-mesenchymal transition by targeting AKT signaling in
endometrial cancer cells. J Obstet Gynaecol Res. 41:1653–1660.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su N, Qiu H, Chen Y, Yang T, Yan Q and Wan
X: miR-205 promotes tumor proliferation and invasion through
targeting ESRRG in endometrial carcinoma. Oncol Rep. 29:2297–2302.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang G, Hou X, Li Y and Zhao M: MiR-205
inhibits cell apoptosis by targeting phosphatase and tensin homolog
deleted on chromosome ten in endometrial cancer Ishikawa cells. BMC
Cancer. 14:4402014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lei L, Huang Y and Gong W: miR-205
promotes the growth, metastasis and chemoresistance of NSCLC cells
by targeting PTEN. Oncol Rep. 30:2897–2902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bai J, Zhu X, Ma J and Wang W: miR-205
regulates A549 cells proliferation by targeting PTEN. Int J Clin
Exp Pathol. 8:1175–1183. 2015.PubMed/NCBI
|
|
28
|
Wang L, Shan M, Liu Y, Yang F, Qi H, Zhou
L, Qiu L and Li Y: miR-205 suppresses the proliferative and
migratory capacity of human osteosarcoma Mg-63 cells by targeting
VEGFA. Onco Targets Ther. 8:2635–2642. 2015.PubMed/NCBI
|
|
29
|
Salajegheh A, Vosgha H, Rahman Md A, Amin
M, Smith RA and Lam AK: Modulatory role of miR-205 in angiogenesis
and progression of thyroid cancer. J Mol Endocrinol. 55:183–196.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H and Fan Q: MicroRNA-205 inhibits
the proliferation and invasion of breast cancer by regulating AMOT
expression. Oncol Rep. 34:2163–2170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang H, Li B, Zhao H and Chang J: The
expression and clinical significance of serum miR-205 for breast
cancer and its role in detection of human cancers. Int J Clin Exp
Med. 8:3034–3043. 2015.PubMed/NCBI
|
|
32
|
Chen Z, Tang ZY, He Y, Liu LF, Li DJ and
Chen X: miRNA-205 is a candidate tumor suppressor that targets ZEB2
in renal cell carcinoma. Oncol Res Treat. 37:658–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim JS, Park SY, Lee SA, Park MG, Yu SK,
Lee MH, Park MR, Kim SG, Oh JS, Lee SY, et al: MicroRNA-205
suppresses the oral carcinoma oncogenic activity via
down-regulation of Axin-2 in KB human oral cancer cell. Mol Cell
Biochem. 387:71–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang N, Li Q, Feng NH, Cheng G, Guan ZL,
Wang Y, Qin C, Yin CJ and Hua LX: miR-205 is frequently
downregulated in prostate cancer and acts as a tumor suppressor by
inhibiting tumor growth. Asian J Androl. 15:735–741. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamaguchi R, Yano H, Iemura A, Ogasawara
S, Haramaki M and Kojiro M: Expression of vascular endothelial
growth factor in human hepatocellular carcinoma. Hepatology.
28:68–77. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miura H, Miyazaki T, Kuroda M, Oka T,
Machinami R, Kodama T, Shibuya M, Makuuchi M, Yazaki Y and Ohnishi
S: Increased expression of vascular endothelial growth factor in
human hepatocellular carcinoma. J Hepatol. 27:854–861. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhuang Y and Wei M: Impact of vascular
endothelial growth factor expression on overall survival in
patients with osteosarcoma: A meta-analysis. Tumour Biol.
35:1745–1749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Y, Zheng Q, Wu H, Guo X, Li J and Hao
S: Rapamycin increases pCREB, Bcl-2, and VEGF-A through ERK under
normoxia. Acta Biochim Biophys Sin (Shanghai). 45:259–267. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wiszniak S, Mackenzie FE, Anderson P,
Kabbara S, Ruhrberg C and Schwarz Q: Neural crest cell-derived VEGF
promotes embryonic jaw extension. Proc Natl Acad Sci USA.
112:6086–6091. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2005. View Article : Google Scholar : PubMed/NCBI
|
